Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Withdrawn 1Completed 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Genitourinary 2

Conditions

Carcinoma, Renal Cell 7Kidney Neoplasms 4Prostatic Neoplasms 3Adenocarcinoma 2Neoplasm Metastasis 1

Interventions

pembrolizumab 6Radiosurgery 5Docetaxel 5enzalutamide 4darolutamide 3Radiotherapy 3Everolimus 3Androgen Antagonists 3relugolix 2luprolide acetate gel depot 2Surveys and Questionnaires 2Standard of Care 2Radiotherapy, Image-Guided 2Radiofrequency Ablation 2Panobinostat 2Leuprolide 2Abiraterone Acetate 2trastuzumab deruxtecan 1talazoparib 1spartalizumab 1siremadlin 1sipuleucel-T 1sargramostim 1resiquimod 1polysaccharide-K 1poly ICLC 1palbociclib 1olaparib 1liposomal doxorubicin 1ixabepilone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Adenocarcinoma × Radiofrequency Ablation × Genitourinary × Clear all
NCT07237399 2026-05-13

TA-P-OLIM

University Hospital, Ghent

Withdrawn
Genitourinary

Adenocarcinoma, Prostatic Neoplasms

NCT02328807 2021-08-06

Focal Prostate Radio-Frequency Ablation

H. Lee Moffitt Cancer Center and Research Institute

Phase NA Completed
6 enrolled 7 charts
Genitourinary

Adenocarcinoma, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡